An anti-neoplastic glycan isolated from Mycobacterium bovis (BCG vaccine). (Q36671024)

13 October 2017

An anti-neoplastic glycan isolated from Mycobacterium bovis (BCG vaccine). (English)

1 reference

13 October 2017

1 reference

Mycobacterium bovis

1 reference

Wang R

1

1 reference

13 October 2017

Klegerman ME

2

1 reference

13 October 2017

Marsden I

3

1 reference

13 October 2017

Sinnott M

4

1 reference

13 October 2017

Groves MJ

5

1 reference

13 October 2017

language of work or name

English

0 references

publication date

1 November 1995

1 reference

13 October 2017

6

1 reference

inferred from page(s)

published in

Biochemical Journal

1 reference

13 October 2017

311 ( Pt 3)

1 reference

13 October 2017

867-872

1 reference

Pharmaceutical characterization of Mycobacterium bovis bacillus Calmette-Guérin (BCG) vaccine used for the treatment of superficial bladder cancer

13 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1136081

Bacillus Calmette-Guérin as an anti-tumor agent. The interaction with cells of the mammalian immune system

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1136081

Suppression of tumor growth at the site of infection with living Bacillus Calmette-Guérin

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1136081

Bacillus Calmette-Guerin immunotherapy for bladder cancer

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1136081

High-dose inhibition and low-dose enhancement of murine sarcoma growth exhibited by BCG vaccine

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1136081

Relative tumor inhibitory and stimulatory activities of BCG vaccine preparations, lots and substrains in a quantitative mouse sarcoma bioassay

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1136081

Assignment of the 1H chemical shifts of glycogen

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1136081

Modulation of immunity by bacillus calmette-guérin (BCG)

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1136081

Immune status in lung cancer: effects of BCG immunotherapy

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1136081

An improved procedure for the methylation analysis of oligosaccharides and polysaccharides

28 June 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/7487943

12 December 2020

inferred from PubMed ID database lookup

Initial characterization of an antineoplastic, polysaccharide-rich extract of Mycobacterium bovis BCG, Tice substrain

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/7487943

12 December 2020

inferred from PubMed ID database lookup

From the Food and Drug Administration

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/7487943

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1042/BJ3110867

1 reference

13 October 2017

1 reference

13 October 2017

1 reference